Lion Biotechnologies Inc
Lion Biotechnologies Inc operates in various business sectors.
Market Cap & Net Worth: Lion Biotechnologies Inc (2LB)
Lion Biotechnologies Inc (STU:2LB) has a market capitalization of $35.28K (€34.37K) as of March 18, 2026. Listed on the STU stock exchange, this Germany-based company holds position #42941 globally and #6814 in its home market, demonstrating a -4.09% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lion Biotechnologies Inc's stock price €3.49 by its total outstanding shares 9845 (9.85K).
Lion Biotechnologies Inc Market Cap History: 2015 to 2026
Lion Biotechnologies Inc's market capitalization history from 2015 to 2026. Data shows change from $69.28K to $35.28K (-4.60% CAGR).
Lion Biotechnologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lion Biotechnologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Lion Biotechnologies Inc's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $78.62K | $1.19 Million | -$444.04 Million | 0.07x | N/A |
Competitor Companies of 2LB by Market Capitalization
Companies near Lion Biotechnologies Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Lion Biotechnologies Inc by market ranking:
- BlackRock TCP Capital Corp (NASDAQ:TCPC): Ranked #42932 globally with a market cap of $34.44K USD.
- Duearity AB (ST:DEAR): Ranked #42933 globally with a market cap of $34.43K USD ( Skr386.30K SEK).
- IMPREGILO (BE:IPJ1): Ranked #42942 globally with a market cap of $34.31K USD ( €33.43K EUR).
- 208850 (KO:208850): Ranked #42943 globally with a market cap of $34.31K USD ( ₩50.24 Million KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42932 | BlackRock TCP Capital Corp | NASDAQ:TCPC | $34.44K | $3.53 |
| #42933 | Duearity AB | ST:DEAR | $34.43K | Skr0.02 |
| #42942 | IMPREGILO | BE:IPJ1 | $34.31K | €3.42 |
| #42943 | 208850 | KO:208850 | $34.31K | ₩5200.00 |
Lion Biotechnologies Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Lion Biotechnologies Inc's market cap moved from $69.28K to $ 35.28K, with a yearly change of -4.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €35.28K | +50.57% |
| 2025 | €23.43K | -66.97% |
| 2024 | €70.94K | -9.77% |
| 2023 | €78.62K | +32.49% |
| 2022 | €59.34K | -65.41% |
| 2021 | €171.54K | -56.18% |
| 2020 | €391.44K | +56.19% |
| 2019 | €250.62K | +223.76% |
| 2018 | €77.41K | +15.43% |
| 2017 | €67.06K | -0.42% |
| 2016 | €67.34K | -2.80% |
| 2015 | €69.28K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Lion Biotechnologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.28K USD |
| MoneyControl | $35.28K USD |
| MarketWatch | $35.28K USD |
| marketcap.company | $35.28K USD |
| Reuters | $35.28K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.